• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

6 Benefits of Telemedicine in Managing the Diabetes Epidemic

Share:

March 31, 2020

The American Diabetes Association reveals that 9.4% of the American population has diabetes, and with numbers that high nearly all Americans have a friend or family member with the disease. However, many Americans are not aware that telehealth can enable diabetic patients to manage their condition—treatment that would have otherwise been difficult to come by for rural patients with limited access to care.

With such a high prevalence among the population, providing care regardless of proximity to a physical doctor is an urgent matter. Dr. David G. Marrero, director of the University of Arizona Health Sciences Center for Border Health Disparities in Tucson, urges, “Diabetes may be the most serious public health crisis of our time.” With nearly 30 million Americans living with diabetes, and more than 84 million at risk of acquiring chronic disease, he isn’t wrong. Once acquired, adults with diabetes are almost twice as likely to die from heart disease or stroke and can experience kidney failure, blindness, amputation, and depression. Annually more than 83,000 people die of diabetes.

6 Benefits of Virtual Health in Managing an Epidemic

Virtual health technologies provide patients with the opportunity to be more active participants in their own care plans. Many diabetic patients already inject themselves with insulin or monitor their blood sugar levels at home and remotely share the results. Progressing to virtual care feels like a natural next step for patients who are often self-reliant, making them ideal candidates to become some of the first-generation telemedicine adopters.

Telemedicine offers six convenient and clinically responsible advantages when it comes to managing diabetes:

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

1. Consistent monitoring: Diabetes requires consistent monitoring. Telehealth can enable round-the-clock digital monitoring, giving providers a 24-hour profile and a better understanding of the patient’s condition.

2. Support for lifestyle modifications: An American Diabetes Association study found that patients can be enabled to lose weight, lower blood pressure, and engage in healthy behavior to curb diabetes with the aid of digital health tools.

3. Patient Engagement: Engagement in treatment can be especially burdensome for rural patients. Providing a telemedical experience can provide rural patients with digital access to medical support from their own homes—thus aiding in the removal of location barriers in treatment.

4. Depression Treatment: People with diabetes are at least twice as likely to suffer from depression as non-diabetics. Low blood sugar creates feelings of lethargy. This can enhance poor eating, a lack of exercise, and general self-neglect which can create a cyclical nature between diabetes and depression. Depression can also be treated digitally through telemedicine.

5. Preventative programs: In rural areas attending in-person, preventative programs can be difficult, but the Centers for Disease Control and Prevention (CDC) is trying to prevent at-risk people from developing type 2 diabetes through their National Diabetes Prevention Programs (DPP). Telehealth helps providers deliver DPP programs to rural areas that otherwise lack specialized diabetes expertise. Through this digital access, rural patients can be provided with online educational materials to assist in preventative measures.

6. Cost control: Diabetes imposes a staggering economic burden on patients and our healthcare system. The American Diabetes Association estimated that the cost of diagnosed diabetes in the U.S. hit $327 billion in 2017, with reduced productivity costing another $90 billion. As Dr. Marrero said, “If you think our healthcare system is stressed now and that the costs are exacerbated, put another 40 to 50 million people with diabetes into the mix, and we’ll be in very deep trouble.” The ability to reach rural people through telemedicine can potentially help curb these numbers.

Controlling an Epidemic with Virtual Health

Recently 19 U.S. senators asked CMS and Health and Human Services Secretary Alex Azar to reimburse telemedicine services to improve outcomes for Americans at risk of developing type 2 diabetes. Their letter stated, “a Medicare beneficiary’s access to the life-improving program should not, and cannot, be determined solely by the zip code in which he or she lives.” This is also the virtual health philosophy for all healthcare needs, for all patients. This philosophy can become a reality as the world increases in computer literacy and becomes more tech-savvy, increasing the use of virtual care technologies and creating equal opportunities to patients regardless of location.

Inherently, telemedicine creates a digital experience that opens avenues for treatment and prevention of diabetes. By removing barriers that inhibit consistent monitoring, creating virtual preventative programs, and controlling costs for the healthcare system, telemedicine can enable patients to become more active in their own healthcare.

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Pharma and Healthcare Social Media Marketing Market Value Will Exhibit a Nominal Uptick in 2020 as Corona Virus Outbreak Prevails as a Global Pandemic, Says Future Market Insights in a Revised Report 2020-2030Pharma and Healthcare Social Media Marketing Market Value Will Exhibit a Nominal Uptick in 2020 as Corona Virus Outbreak Prevails as a Global Pandemic, Says Future Market Insights in a Revised Report 2020-2030
  • Chinook Therapeutics Closes Merger with Aduro Biotech and Completes $115 Million Private Placement FinancingChinook Therapeutics Closes Merger with Aduro Biotech and Completes $115 Million Private Placement Financing
  • How Pharmaceutical Companies can Capture Maximum Value from M&A: Infiniti Research Reveals Key Considerations for Pharma M&A SuccessHow Pharmaceutical Companies can Capture Maximum Value from M&A: Infiniti Research Reveals Key Considerations for Pharma M&A Success
  • Digital Health Researchers Flock to Smart Clothing in Studying Sweat & COVID-19Digital Health Researchers Flock to Smart Clothing in Studying Sweat & COVID-19
  • India-Based Virtual Health Company MediBuddy Nabs $125M in Series C FundingIndia-Based Virtual Health Company MediBuddy Nabs $125M in Series C Funding
  • Fitbit, FibriCheck Expand Partnership to Deliver CE-Marked Heart Health Detection App in EuropeFitbit, FibriCheck Expand Partnership to Deliver CE-Marked Heart Health Detection App in Europe
  • German Health Data Company Temedica Scores €25MGerman Health Data Company Temedica Scores €25M
  • Amazon Pharmacy Partners with Five Blues Plans to Offer Prescription Discount CardAmazon Pharmacy Partners with Five Blues Plans to Offer Prescription Discount Card

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications